SIXTH WAVE AMIPS™ EXPANDS DETECTION CAPABILITIES TO INCLUDE PREVALENT FOODBORNE PATHOGENS SALMONELLA AND LISTERIA

Halifax, Nova Scotia – Sixth Wave Innovations Inc. (CSE:SIXW) (OTCQB:SIXWF) (FSE:AHUH) (“Sixth Wave”, “SIXW” or the “Company”) is pleased to announce that its patent pending Accelerated Molecularly Imprinted Polymer (“AMIPs™”) technology has expanded its library of detectable pathogens, such as E.coli, to include bacteria for Salmonella, Listeria, and Sarcina. Sixth Wave has integrated new bacteria-imprinted [...]

Repligen Extends and Expands Long-Term Supply Agreement with Purolite for Affinity Ligands

WALTHAM, Mass. -- Repligen Corporation (NASDAQ:RGEN) today announced that is has extended its long-term supply agreement with Purolite, An Ecolab Company (“Purolite”), for the development and manufacturing of affinity ligands focused on monoclonal antibodies (“mAb”) and antibody fragments. Repligen entered into an exclusive agreement with Purolite in 2018 for the development and supply of NGL-Impact® Protein [...]

Illumina Introduces New Research Test to Address One of the Most Common Infections in the United States

Panel leverages precision metagenomics to transform testing for urinary tract infections Newest kit follows recent launch of panel testing for 66 viral pathogens that pose persistent threats to global public health SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, today announced a new research test for genitourinary pathogen and antimicrobial resistance (AMR) [...]

Hitachi High-Tech America, Inc. expands its Analytical Systems Division

Dallas, TX -- Hitachi High-Tech America, Inc. (HTA), an American subsidiary of Hitachi High-Tech Corporation (Hitachi High-Tech: Tokyo, Japan), today announced the expansion of its Analytical Systems Division (ASD) by incorporating the business operations of two other Hitachi High-Tech Group companies: Hitachi High-Tech Analytical Science America, Inc. (HHA-US), and Hitachi High-Tech Science America, Inc. (HHS-US). [...]

Getinge’s bioreactors to support unique Dutch cellular agriculture initiative

The Dutch government confirms allocation of €60 million to support an ecosystem around cellular agriculture, the technology used to produce animal products such as meat and milk proteins directly from animal and microbial cells. As member of the Cellular Agriculture Netherlands Foundation, Getinge will support the project with its bioreactors and bioreactor knowledge. Getinge is [...]

Cytek® Biosciences Names Chris Williams Chief Operating Officer

Experienced Biotech, Pharmaceutical Industry Leader to Guide Operations Growth and Scalability FREMONT, Calif. -- Cytek Biosciences, Inc. (Nasdaq: CTKB) today announced that Chris Williams has been appointed chief operating officer for the company. In this role, Williams will lead and execute the company’s global operations strategy to scale up its capability to support its mission as [...]

CellChorus adopts Scispot’s tech stack to scale their life science startup

KITCHENER, Ontario -- Scispot, a leading life science informatics company for biostartups, announced today that CellChorus, a dynamic single-cell analysis company, has adopted the Scispot platform to build their company for rapid scaling. CellChorus uses Scispot to design and standardize their research workflows and to automate their inventory consumption and product ordering. "CellChorus works with [...]

Beckman Coulter Life Sciences and Pillar Biosciences Sign Application Development Agreement for the Biomek NGeniuS System

INDIANAPOLIS – More companies around the world continue turning to Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, for their next generation sequencing (NGS) needs with the Biomek NGeniuS System. The company continues building a robust demonstrated application library as it announces an application development agreement with Pillar Biosciences, which specializes [...]

Thompson Street Capital Partners Portfolio Company LifeSpan Biosciences Becomes Absolute Biotech

ST. LOUIS -- Thompson Street Capital Partners (TSCP), a private equity firm based in St. Louis, announced that LifeSpan Biosciences, a TSCP portfolio company, has become Absolute Biotech, a unified holding company joining together leading antibody-centric brands from around the world. Absolute Biotech specializes in antibody reagents and services, adding value to existing antibodies, reagents [...]

Eagle Genomics Announces USD 20M First Close; Scale-up Funding to Accelerate the Application of Microbiome Science for Global ‘One Health’ Innovation

Funds to support scale-up, including continued development of AI-augmented knowledge discovery platform, the e[datascientist]™, and continued international expansion  Platform business focused on bridging the current ‘translation gap’, addressing critical bottlenecks in the industrial application of microbiome science – from soil, to plant, to farm, to fork, to human, to animals, and environmental health  Round led [...]

Access IBO on Knowledge Center